Rtw Investments as of June 30, 2022
Portfolio Holdings for Rtw Investments
Rtw Investments holds 107 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 6.3 | $246M | 1.7M | 145.85 | |
| Thermo Fisher Scientific (TMO) | 6.1 | $237M | 436k | 543.28 | |
| Rocket Pharmaceuticals (RCKT) | 5.6 | $217M | 16M | 13.76 | |
| Ptc Therapeutics I (PTCT) | 5.2 | $202M | 5.0M | 40.06 | |
| Masimo Corporation (MASI) | 4.6 | $177M | 1.4M | 130.67 | |
| Argenx Se Sponsored Adr (ARGX) | 4.3 | $168M | 443k | 378.88 | |
| Immunocore Hldgs Ads (IMCR) | 3.9 | $149M | 4.0M | 37.31 | |
| Establishment Labs Holdings Ord (ESTA) | 3.3 | $129M | 2.4M | 54.38 | |
| Mirati Therapeutics | 3.3 | $126M | 1.9M | 67.13 | |
| Illumina (ILMN) | 2.7 | $104M | 564k | 184.36 | |
| Cytokinetics Com New (CYTK) | 2.6 | $101M | 2.6M | 39.29 | |
| Prometheus Biosciences | 2.3 | $90M | 3.2M | 28.23 | |
| Vericel (VCEL) | 2.3 | $89M | 3.5M | 25.18 | |
| Penumbra (PEN) | 2.2 | $87M | 698k | 124.52 | |
| Celldex Therapeutics Com New (CLDX) | 2.1 | $83M | 3.1M | 26.96 | |
| Ultragenyx Pharmaceutical (RARE) | 2.1 | $82M | 1.4M | 59.66 | |
| Natera (NTRA) | 1.9 | $75M | 2.1M | 35.44 | |
| Avidity Biosciences Ord (RNA) | 1.8 | $70M | 4.8M | 14.53 | |
| Axonics Modulation Technolog (AXNX) | 1.7 | $67M | 1.2M | 56.67 | |
| Cutera | 1.7 | $66M | 1.8M | 37.50 | |
| Globus Med Cl A (GMED) | 1.6 | $63M | 1.1M | 56.14 | |
| Pmv Pharmaceuticals (PMVP) | 1.6 | $63M | 4.4M | 14.25 | |
| Axsome Therapeutics (AXSM) | 1.6 | $62M | 1.6M | 38.30 | |
| ACADIA Pharmaceuticals (ACAD) | 1.5 | $60M | 4.2M | 14.09 | |
| Adicet Bio (ACET) | 1.5 | $58M | 4.0M | 14.60 | |
| Tandem Diabetes Care Com New (TNDM) | 1.4 | $55M | 923k | 59.19 | |
| Relmada Therapeutics (RLMD) | 1.3 | $50M | 2.6M | 18.99 | |
| Stoke Therapeutics (STOK) | 1.2 | $48M | 3.7M | 13.21 | |
| Regenxbio Inc equity us cm (RGNX) | 1.2 | $46M | 1.8M | 24.70 | |
| 10x Genomics Cl A Com (TXG) | 1.1 | $43M | 960k | 45.25 | |
| Protagonist Therapeutics (PTGX) | 1.0 | $38M | 4.8M | 7.91 | |
| Guardant Health (GH) | 1.0 | $37M | 925k | 40.34 | |
| Quanterix Ord (QTRX) | 0.8 | $30M | 1.8M | 16.19 | |
| Tarsus Pharmaceuticals (TARS) | 0.8 | $29M | 2.0M | 14.60 | |
| Milestone Pharmaceuticals (MIST) | 0.7 | $27M | 4.3M | 6.15 | |
| Cincor Pharma | 0.7 | $26M | 1.4M | 18.84 | |
| Female Health (VERU) | 0.6 | $25M | 2.2M | 11.30 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.6 | $24M | 1.6M | 15.20 | |
| C4 Therapeutics Com Stk (CCCC) | 0.6 | $23M | 3.1M | 7.54 | |
| Gh Research Ordinary Shares (GHRS) | 0.6 | $22M | 2.2M | 9.98 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.6 | $21M | 1.3M | 16.78 | |
| Castle Biosciences (CSTL) | 0.5 | $20M | 914k | 21.95 | |
| Apyx Medical Corporation (APYX) | 0.5 | $20M | 3.4M | 5.86 | |
| Fulcrum Therapeutics (FULC) | 0.5 | $19M | 4.0M | 4.90 | |
| Ventyx Biosciences (VTYX) | 0.5 | $19M | 1.6M | 12.23 | |
| Dermtech Ord ord (DMTKQ) | 0.4 | $17M | 3.1M | 5.54 | |
| 2seventy Bio Common Stock | 0.4 | $16M | 1.2M | 13.20 | |
| Avadel Pharmaceuticals Sponsored Adr | 0.4 | $14M | 5.7M | 2.44 | |
| Tenaya Therapeutics (TNYA) | 0.4 | $14M | 2.5M | 5.63 | |
| Outset Med | 0.3 | $14M | 910k | 14.86 | |
| Jounce Therapeutics | 0.3 | $13M | 4.4M | 3.03 | |
| Monte Rosa Therapeutics (GLUE) | 0.3 | $12M | 1.2M | 9.67 | |
| Macrogenics (MGNX) | 0.3 | $12M | 4.0M | 2.95 | |
| 908 Devices (MASS) | 0.3 | $11M | 513k | 20.59 | |
| Cryoport Com Par $0.001 (CYRX) | 0.3 | $10M | 335k | 30.98 | |
| Pulmonx Corp (LUNG) | 0.3 | $10M | 691k | 14.72 | |
| Align Technology (ALGN) | 0.3 | $9.9M | 42k | 236.67 | |
| Cytek Biosciences (CTKB) | 0.3 | $9.8M | 917k | 10.73 | |
| Codexis (CDXS) | 0.2 | $9.6M | 920k | 10.46 | |
| Immunic (IMUX) | 0.2 | $9.6M | 2.8M | 3.47 | |
| Somalogic Class A Com | 0.2 | $9.6M | 2.1M | 4.52 | |
| Twist Bioscience Corp (TWST) | 0.2 | $9.4M | 270k | 34.96 | |
| Aadi Bioscience (WHWK) | 0.2 | $9.4M | 765k | 12.32 | |
| Sight Sciences (SGHT) | 0.2 | $9.0M | 997k | 8.99 | |
| Oyster Point Pharma | 0.2 | $8.9M | 2.1M | 4.33 | |
| Science 37 Holdings | 0.2 | $8.6M | 4.3M | 2.01 | |
| Essa Pharma Com New (EPIX) | 0.2 | $8.3M | 2.6M | 3.15 | |
| Brainsway Sponsored Ads (BWAY) | 0.2 | $7.7M | 1.6M | 4.83 | |
| La Jolla Pharmaceutical Com Par $.0001 2 | 0.2 | $7.4M | 2.3M | 3.19 | |
| Tela Bio (TELA) | 0.2 | $7.1M | 1.0M | 7.01 | |
| Urogen Pharma (URGN) | 0.2 | $7.0M | 858k | 8.19 | |
| Research Alliance Corp Ii Com Cl A | 0.2 | $6.2M | 637k | 9.77 | |
| Renovacor | 0.2 | $6.1M | 3.0M | 2.03 | |
| Bcls Acquisition Corp Com Cl A | 0.2 | $6.1M | 613k | 9.90 | |
| Exagen (XGN) | 0.2 | $5.9M | 1.0M | 5.74 | |
| Procept Biorobotics Corp (PRCT) | 0.1 | $5.3M | 161k | 32.69 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $5.2M | 2.8M | 1.83 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $4.9M | 500k | 9.81 | |
| Summit Healthcre Acquistn Unit 06/03/2026 | 0.1 | $4.9M | 500k | 9.75 | |
| Arya Sciences Acquisitn Corp Class A Ord Shs | 0.1 | $4.9M | 500k | 9.72 | |
| 5 01 Acquisition Corp Com Cl A | 0.1 | $3.9M | 392k | 9.89 | |
| Maxcyte (MXCT) | 0.1 | $3.7M | 773k | 4.73 | |
| Point Biopharma Global | 0.1 | $3.3M | 490k | 6.81 | |
| Roivant Sciences SHS (ROIV) | 0.1 | $3.3M | 803k | 4.07 | |
| Johnson & Johnson (JNJ) | 0.1 | $3.2M | 18k | 177.53 | |
| Nyxoah S A SHS (NYXH) | 0.1 | $3.2M | 345k | 9.20 | |
| Landos Biopharma | 0.1 | $3.1M | 4.3M | 0.73 | |
| Agenus Com New | 0.1 | $3.1M | 1.6M | 1.94 | |
| Immatics SHS (IMTX) | 0.1 | $3.0M | 350k | 8.71 | |
| Akoya Biosciences (AKYA) | 0.1 | $3.0M | 234k | 12.85 | |
| Nautilus Biotechnology (NAUT) | 0.1 | $3.0M | 1.1M | 2.69 | |
| Medicus Sciences Acquisition Cl A Shs | 0.1 | $2.9M | 300k | 9.78 | |
| Cti Biopharma | 0.1 | $2.8M | 472k | 5.97 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.1 | $2.6M | 500k | 5.25 | |
| Rxsight (RXST) | 0.1 | $2.1M | 150k | 14.08 | |
| Genetron Hldgs Ads | 0.1 | $2.0M | 1.2M | 1.70 | |
| Pyxis Oncology Common Stock (PYXS) | 0.0 | $1.6M | 682k | 2.38 | |
| Aslan Pharmaceuticals Ads | 0.0 | $1.6M | 3.3M | 0.50 | |
| Miromatrix Med | 0.0 | $1.1M | 280k | 3.99 | |
| Apollo Endosurgery | 0.0 | $942k | 258k | 3.65 | |
| Isoplexis Corp | 0.0 | $788k | 365k | 2.16 | |
| Avita Therapeutics (RCEL) | 0.0 | $507k | 107k | 4.75 | |
| Minerva Surgical | 0.0 | $390k | 166k | 2.35 | |
| Singular Genomics Systems In | 0.0 | $382k | 100k | 3.82 | |
| Codex Dna | 0.0 | $180k | 100k | 1.80 | |
| Renovacor *w Exp 99/99/999 | 0.0 | $21k | 350k | 0.06 | |
| Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $6.0k | 33k | 0.18 |
